IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today announced it will present at the Jefferies 2010 Global Life Sciences Conference at 8:00 a.m. Eastern Time on June 9, 2010, in New York, NY. ISTA’s President and Chief Executive Officer Vicente Anido, Jr., Ph.D., will provide an update on the Company’s marketed products and clinical programs.
The presentation will be webcast. To access the live audio broadcast of the presentation, or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.
ABOUT ISTA PHARMACEUTICALS
ISTA Pharmaceuticals, Inc., is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA’s four marketed products plus its product candidates include therapies for inflammation, ocular pain, allergy, glaucoma, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share. For additional information regarding ISTA, please visit ISTA Pharmaceuticals’ website at http://www.istavision.com.
SOURCE ISTA Pharmaceuticals, Inc.
